The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 22312159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2011cited by this paper
• Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow‐up project of the German–Austrian DAL‐HD studies

  2010cited by this paper
• Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.

  2010cited by this paper
• Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

  2009cited by this paper
• Quality of systematic reviews in pediatric oncology--a systematic review.

  2009cited by this paper
• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2009cited by this paper
• Alternatives to the randomized controlled trial.

  2008cited by this paper
• Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care.

  2008cited by this paper
• Meta‐analysis of B type natriuretic peptide and N‐terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction

  2008cited by this paper
• Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group

  2008cited by this paper
• Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.

  2007cited by this paper
• Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review.

  2007cited by this paper
• Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

  2007cited by this paper
• Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease.

  2007cited by this paper
• Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

  2006cited by this paper
• Long-term follow-up of people who have survived cancer during childhood.

  2006cited by this paper
• Long‐term follow‐up of childhood cancer survivors: Future directions for clinical care and research

  2006cited by this paper
• Long-term cardiac follow-up in survivors of a malignant bone tumour.

  2006cited by this paper
• Chronic health conditions in adult survivors of childhood cancer.

  2006cited by this paper
• Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

  2006cited by this paper
• Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.

  2005cited by this paper
• Survivors of childhood and adolescent cancer : a multidisciplinary approach

  2005cited by this paper
• Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

  2005cited by this paper
• Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.

  2004cited by this paper
• Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy

  2004cited by this paper
• Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

  2004cited by this paper
• Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function

  2004cited by this paper
• Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines.

  2004cited by this paper
• [Evidence-based guideline development in the Netherlands: the EBRO platform].

  2004cited by this paper
• Long‐term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk‐based Health Care for Survivors

  2004cited by this paper
• Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children.

  2003cited by this paper
• Late anthracycline cardiotoxicity after childhood cancer

  2003cited by this paper
• Pregnancy outcome in women treated with doxorubicin for childhood cancer.

  2003cited by this paper
• Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community

  2003cited by this paper
• Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.

  2003cited by this paper
• Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.

  2003cited by this paper
• Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

  2002cited by this paper
• Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

  2002cited by this paper
• Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

  2001cited by this paper
• Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Anthracycline-induced cardiotoxicity.

  2000cited by this paper
• Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.

  1999cited by this paper
• Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.

  1997cited by this paper
• Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin.

  1997cited by this paper
• Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions.

  1996cited by this paper
• Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction.

  1996cited by this paper
• Anthracycline-Induced Cardiotoxicity

  1996cited by this paper
• A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

  1995cited by this paper
• Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

  1995cited by this paper
• Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

  1992cited by this paper
• Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study).

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• PERIPARTUM HEART FAILURE IN A PATIENT TREATED PREVIOUSLY WITH DOXORUBICIN

  1988cited by this paper
• Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study

  year unknowncited by this paper

• Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016–2024)

  2026cites this paper
• Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach

  2025cites this paper
• The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review

  2024cites this paper
• Cardio-oncology for Pediatric and Adolescent/Young Adult Patients

  2023cites this paper
• Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?

  2023cites this paper
• What it looks like to ‘mind the gaps’ in a Midwest survivorship clinic for childhood cancer survivors

  2023cites this paper
• Myocardial Strain during Surveillance Screening Is Associated with Future Cardiac Dysfunction among Survivors of Childhood, Adolescent and Young Adult-Onset Cancer

  2023cites this paper
• Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography.

  2023cites this paper
• Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review

  2022cites this paper
• Long-term care, care needs and wellbeing of individuals after cancer in childhood or adolescence (VersKiK): study protocol of a large scale multi-methods non-interventional study

  2022cites this paper
• Current State of Pediatric Cardio-Oncology: A Review

  2022cites this paper
• Cardiometabolic risk in childhood cancer survivors.

  2021cites this paper
• Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer

  2021cites this paper
• Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy

  2021cites this paper
• Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging.

  2020cites this paper
• Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

  2020cites this paper
• Long-Term Follow-Up Guidelines and Organization of Long-Term Follow-Up Care for Childhood and Young Adult Cancer Survivors

  2020cites this paper
• Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy

  2020cites this paper
• Healthcare professionals' opinions on psychological screening in follow-up care for childhood cancer survivors.

  2020cites this paper
• Cardiovascular disease and asymptomatic childhood cancer survivors: Current clinical practice

  2020cites this paper
• Cardiovascular Toxicities in Pediatric Cancer Survivors.

  2019cites this paper
• Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study.

  2019cites this paper
• Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer

  2019cites this paper
• Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study

  2019influential citation
• Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review

  2019cites this paper
• Towards evidence-based management of patients treated with cardiotoxic chemotherapy: A collaborative effort of cardiologists and oncologists

  2018cites this paper
• Pregnancy and Cardiomyopathy After Anthracyclines in Childhood

  2018cites this paper
• Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review

  2018cites this paper
• Cardio-toxicity in childhood cancer survivors "Cure is not enough".

  2018cites this paper
• University of Groningen Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer Sieswerda,

  2018cites this paper
• Late Mortality and Cardiovascular Morbidity After Cancer at a Young Age in Finland

  2017cites this paper
• Cardiovascular Risk in Survivors of Cancer

  2017cites this paper
• Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future

  2016cites this paper
• The Cost of Cure: Chronic Conditions in Survivors of Child, Adolescent, and Young Adult Cancers

  2016cites this paper
• Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.

  2016cites this paper
• Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331

  2016cites this paper
• The European Experience of Establishing Guidelines for Surveillance of the Childhood Cancer Survivor

  2015cites this paper
• Individual prediction of heart failure among childhood cancer survivors.

  2015cites this paper
• Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

  2015cites this paper
• Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.

  2015cites this paper
• Childhood cancer survivor cohorts in Europe

  2015cites this paper
• Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

  2015cites this paper
• Approaches to reduce the long-term burden of treatment-related complications in survivors of childhood cancer.

  2015cites this paper
• Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

  2015cites this paper
• A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies

  2015cites this paper
• Quality and safety in pediatric hematology/oncology

  2014cites this paper
• Fertility in Hodgkin lymphoma survivors

  2014cites this paper
• Screening for Cardiac Dysfunction in Anthracycline-Exposed Childhood Cancer Survivors

  2014cites this paper
• Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma

  2014cites this paper
• Impact of cancer in childhood, adolescence, and young adulthood on death, social security benefit uptake and education. A nationwide population-based cohort study

  2014cites this paper
• Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study

  2013cites this paper
• Developing international consensus for late effects screening and guidance

  2013cites this paper
• Late Complications of Cancer in Childhood and Adolescence

  2013cites this paper
• Current World Literature

  2013cites this paper
• Transmural strain and rotation gradient in survivors of childhood cancers.

  2013cites this paper
• Cardiac toxicity in cancer survivors

  2013cites this paper
• Pregnancy unbosoms the heart of breast cancer survivors.

  2012cites this paper